Search research articles
Contact Us
Filters
Showing results (171-180 of 209) with videos related to
Page
of 21
Sort By:
Cell Reports
|
June 1, 2017
Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
Andrea E Calvert, Alexandra Chalastanis, Yongfei Wu, et al.
JAMA Oncology
|
December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review
Craig Horbinski, David A Solomon, Rimas V Lukas, et al.
The Journal of Clinical Investigation
|
April 27, 2023
Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors
Michael R Drumm, Wenxia Wang, Thomas K Sears, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma
Erik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
Research Square
|
October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205
Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
Stem Cells (Dayton, Ohio)
|
April 17, 2014
Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression
James S Hale, Balint Otvos, Maksim Sinyuk, et al.
The Journal of Clinical Investigation
|
November 28, 2023
Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice
Milagros C Romay, Russell H Knutsen, Feiyang Ma, et al.
Nature Medicine
|
February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Brain Pathology (Zurich, Switzerland)
|
February 27, 2013
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma
Joanna J Phillips, Derick Aranda, David W Ellison, et al.
Journal of Medicinal Chemistry
|
November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
Lakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 209) with videos related to
Sort By:
Page
of 21
Cell Reports
|
June 1, 2017
Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
Andrea E Calvert, Alexandra Chalastanis, Yongfei Wu, et al.
JAMA Oncology
|
December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review
Craig Horbinski, David A Solomon, Rimas V Lukas, et al.
The Journal of Clinical Investigation
|
April 27, 2023
Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors
Michael R Drumm, Wenxia Wang, Thomas K Sears, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma
Erik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
Research Square
|
October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205
Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
Stem Cells (Dayton, Ohio)
|
April 17, 2014
Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression
James S Hale, Balint Otvos, Maksim Sinyuk, et al.
The Journal of Clinical Investigation
|
November 28, 2023
Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice
Milagros C Romay, Russell H Knutsen, Feiyang Ma, et al.
Nature Medicine
|
February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Brain Pathology (Zurich, Switzerland)
|
February 27, 2013
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma
Joanna J Phillips, Derick Aranda, David W Ellison, et al.
Journal of Medicinal Chemistry
|
November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
Lakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Page
of 21